SCHEMBL23928577

SCHEMBL23928577

C/C(=N\Nc1ccccc1Cl)c1ccc(S(C)(=O)=O)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.53
MAPT P10636 4/20 0.53
ALDH1A1 P00352 3/20 0.53
TDP1 Q9NUW8 2/20 0.53
KDM4E B2RXH2 2/20 0.53
FAAH O00519 6/20 0.50
MGLL Q99685 5/20 0.50
KMT2A Q03164 3/20 0.47
ALPI P09923 1/20 0.47
LMNA P02545 1/20 0.47
POLB P06746 1/20 0.44
APEX1 P27695 1/20 0.44
PTGS2 P35354 1/20 0.43
HTT P42858 2/20 0.43
MEN1 O00255 2/20 0.42
HPGD P15428 1/20 0.42
CRHBP P24387 1/20 0.42
CRHR2 Q13324 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CA1 P00915 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23928565 0.83 FAAH (0.50) MAPTALDH1A1TDP1FAAHMGLL
SCHEMBL17913102 0.83 CA12 (0.56) GAAMAPTALDH1A1TDP1KDM4E
SCHEMBL23928556 0.80 FAAH (0.46) GAAMAPTALDH1A1FAAHMGLL
SCHEMBL8308765 0.80 FAAH (0.68) GAAMAPTALDH1A1TDP1KDM4E
SCHEMBL23928529 0.76 MAPT (0.64) GAAMAPTALDH1A1TDP1FAAH
SCHEMBL9901358 0.75 RAB9A (0.68) GAAMAPTALDH1A1KMT2ALMNA
SCHEMBL23928536 0.74 FAAH (0.70) GAAMAPTALDH1A1TDP1KDM4E
SCHEMBL23928604 0.74 GAA (0.60) GAAMAPTALDH1A1TDP1KDM4E
SCHEMBL23928652 0.72 FAAH (0.54) GAAMAPTALDH1A1TDP1KDM4E
SCHEMBL23928537 0.71 MAPT (0.67) GAAMAPTALDH1A1TDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11548875-B2 Inhibitor compounds for male contraception UNIVERSITY OF WASHINGTON (US) 2023-01-10 US disclosed
US-20210332030-A1 INHIBITOR COMPOUNDS FOR MALE CONTRACEPTION UNIVERSITY OF WASHINGTON (US) 2021-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210332030-A1 INHIBITOR COMPOUNDS FOR MALE CONTRACEPTION ALDH1A1, ALDH3A1, ALDH16A1 GAA 3740/4885MAPT 4083/4885ALDH1A1 1/4885
US-11548875-B2 Inhibitor compounds for male contraception ALDH1A1, ALDH3A1, ALDH16A1 GAA 3740/4885MAPT 4083/4885ALDH1A1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.